Rapid Plasma Kallikrein Inhibition Following Oral KVD900 is Associated With Early Symptom Relief in Patients With Hereditary Angioedema

Duckworth, E., Feener, E., Yea, C. et al. (3 more authors) (2022) Rapid Plasma Kallikrein Inhibition Following Oral KVD900 is Associated With Early Symptom Relief in Patients With Hereditary Angioedema. In: 2022 AAAAI Annual Meeting, 25-28 Feb 2022, Phoenix, Arizona.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Duckworth, E.
  • Feener, E.
  • Yea, C.
  • Audhya, P.
  • Hampton, S.
  • Smith, M.
Dates:
  • Published: February 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Oct 2024 10:32
Last Modified: 07 Oct 2024 10:32
Published Version: https://www.jacionline.org/article/S0091-6749(21)0...
Status: Published
Identification Number: 10.1016/j.jaci.2021.12.553
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)